MMA
SWAV

Miracle Mile Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Miracle Mile Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,937
Closed -$4.54M – 541
2024
Q1 		$4.54M Hold
13,937
– – 0.11% 115
2023
Q4 		$2.66M Sell
13,937
-540
-4% -$102K 0.07% 151
2023
Q3 		$2.88M Buy
+14,477
New +$3.42M 0.09% 137

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Miracle Mile Advisors's SWAV Position: Q2 2024 in Review

Miracle Mile Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 13,937 shares — an estimated $4.54M sold.

Miracle Mile Advisors first reported a position in SWAV in Q3 2023 and held it in 3 quarters. The position peaked at $4.54M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Miracle Mile Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Miracle Mile Advisors sold 13,937 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $4.54M.
  • Miracle Mile Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Miracle Mile Advisors's Shockwave Medical, Inc. Common Stock position peaked at $4.54M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Miracle Mile Advisors's 13F filing for Q2 2024, filed 18 Jul 2024.